US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

212.22

-1.3400-0.63%

Volume:816.16K

Turnover:172.55M

Market Cap:10.67B

PE:33.62

High:213.46

Open:212.74

Low:210.09

Close:213.56

52wk High:217.06

52wk Low:136.89

Shares:50.30M

Float Shares:50.30M

Volume Ratio:0.52

T/O Rate:1.62%

Dividend:0.41

Dividend Rate:0.19%

EPS(TTM):6.31

EPS(LYR):-1.4940

ROE:24.54%

ROA:0.10%

PB:1.31

PE(LYR):-142.05

Loading ...

Overview Company News Filings

Tango Falls After Wider-than-Expected Quarterly Loss

Jefferies Remains a Buy on Vertex Pharmaceuticals (VRTX)

Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

Vertex Pharmaceuticals Incorporated : Bofa Global Research Adds Stock to Its US 1 List

THOMSON REUTERS

Infinimmune Raises $75 Million Series a Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory Disease

BIO-key International Enters into $2.5 Million Warrant Inducement Transaction

Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development

Infinimmune: $75 Mln Series a Financing Co-Led by Regeneron Ventures and Playground Global

THOMSON REUTERS

Vertex Pharmaceuticals added to ‘US 1 List’ at BofA

AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $633 from $610

THOMSON REUTERS

Breaking News

MT Newswires Live

Lakefront Biotherapeutics Boosts Immunology Push With Ouro Deal and Strong Cash Outlook

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Lakefront Biotherapeutics H1 FY26 Net Sales Drop 87% to EUR 18.6 Million; Operating Loss Narrows 54% to EUR 107.2 Million

Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX)

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

Vertex Pharmaceuticals jumps 7% after rival's drug trial fails to meet key goals

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/IBB/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":212.22,"timestamp":1787595803428,"preClose":213.56,"halted":0,"volume":816161,"delay":0,"changeRate":-0.006274583255291269,"floatShares":50300000,"shares":50300000,"eps":6.311863,"marketStatus":"Trading","change":-1.34,"latestTime":"08-24 14:23:26 EDT","open":212.735,"high":213.46,"low":210.09,"amount":172551346.66147,"amplitude":0.01578,"askPrice":212.25,"askSize":22,"bidPrice":212.21,"bidSize":20,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":213.56,"sharesOutstanding":49450000,"nav":213.623549,"aum":10681177450,"dividendRate":0.001912,"bidAskSpread":0.000342,"preHourTrading":{"tag":"盘前","latestPrice":213.39,"preClose":213.56,"latestTime":"09:29 EDT","volume":1963,"amount":420356.78074,"timestamp":1787578199999,"change":-0.17,"changeRate":-0.000796,"amplitude":0.016623},"postHourTrading":{"tag":"盘后","latestPrice":214.49,"preClose":213.56,"latestTime":"19:57 EDT","volume":10048,"amount":2146390.3292,"timestamp":1787356664368,"change":0.93,"changeRate":0.004355,"amplitude":0.004355},"volumeRatio":0.515102,"impliedVol":0.2402,"impliedVolPercentile":0.6335},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50300000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.515102,"shares":50300000,"dividePrice":0.4058,"high":213.46,"amplitude":0.01578,"preClose":213.56,"low":210.09,"week52Low":136.89,"pbRate":"1.31","psRate":"256.82","week52High":217.06,"institutionHeld":0,"latestPrice":212.22,"committee":-0.047619,"eps":6.311863,"divideRate":0.001912,"volume":816161,"delay":0,"ttmEps":6.311863,"open":212.735,"prevYearClose":168.77,"prevWeekClose":213.56,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":201.93,"twentyDayClose":188.33,"sixtyDayClose":172.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658115349","title":"Tango Falls After Wider-than-Expected Quarterly Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658115349","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658115349?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:18","pubTimestamp":1786461505,"startTime":"0","endTime":"0","summary":"BUZZ-Tango falls after wider-than-expected quarterly loss** Shares of drug developer Tango TherapeuticsTNGX.Ofall 3.3% to $26.75** Co reportsQ2 lossof 37 cents/share, vs. analysts' average loss estima","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N44814E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU0861579265.USD","CANC","PTH","BK4583","BBH","LU1934455277.USD","RVMD","LU0965509010.AUD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU1066051498.USD","IBBQ","LU1674673691.USD","LU2087621335.USD","LU0320765992.SGD","LU0289739699.SGD","LU0114720955.EUR","IE00B4R5TH58.HKD","LU1674673428.USD","TMED","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU2468319806.SGD","BK4139","IE0002270589.USD","LU1778281490.HKD","IE00BJT1NW94.SGD","LU0965508806.USD","IDNA","SG9999015952.SGD","TNGX","LU1037948897.HKD","MEDI","IE0009355771.USD","BK4532","GILD","IBB","BK4585","LU0109394709.USD","BIB","BK4588","IE00B7SZLL34.SGD","BMED","IE00B19Z3581.USD","LU0234570918.USD","LU2324357040.USD","LU1934455863.HKD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919006","title":"Jefferies Remains a Buy on Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919006?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:56","pubTimestamp":1786460205,"startTime":"0","endTime":"0","summary":"Jefferies analyst Akash Tewari maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $633.00. According to TipRanks, Te...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541273.HKD","LU2468319806.SGD","LU0320765992.SGD","LU2236285917.USD","LU0566484027.USD","LU1430594728.SGD","SG9999001176.USD","LU0432979614.USD","LU1069344957.HKD","IDNA","LU0289739699.SGD","IBBQ","BK4533","LU2417539215.USD","LU0061475181.USD","LU1093756168.USD","PBE","IE0002141913.USD","IE00B894F039.SGD","LU0234570918.USD","LU2237438978.USD","TBXU","LU0889565916.HKD","IE00B19Z3581.USD","BK4585","LU0757428866.USD","LU2089984988.USD","IE00B19Z3B42.SGD","LU2462157665.USD","VERX","BK4139","BIB","BK4023","IE00BFTCPJ56.SGD","LU2324357040.USD","LU1778281490.HKD","GNMX","VRTX","BBH","BK4588","IBB","IE00B19Z9P08.USD","IE00B2B36J28.USD","LU0058720904.USD","SGXZ57979304.SGD","LU2362541513.USD","IE00B19Z9Z06.USD","SG9999013999.USD","LU1815336091.USD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658657916","title":"Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2658657916","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658657916?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:01","pubTimestamp":1786456868,"startTime":"0","endTime":"0","summary":"Neurogene ( ($NGNE) ) just unveiled an announcement. Neurogene reported strong progress in its NGN-401 gene therapy program for Rett syndrome, high...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurogene-advances-rett-gene-therapy-program-and-extends-cash-runway-to-2029?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurogene-advances-rett-gene-therapy-program-and-extends-cash-runway-to-2029?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SYNB","LFSC","CNCR","GNOM","TBXU","FBT","BK4588","IBBQ","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658913504","title":"Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658913504","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658913504?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:00","pubTimestamp":1786453226,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","XLV","LU2756315318.SGD","LU0353189680.USD","LU2756315664.SGD","LU0320765992.SGD","LU2417539215.USD","BIB","TBXU","VRTX","UXI","TRUI","MISL","LGHT","LU0820561909.HKD","LU1261432733.SGD","IBB","BBH","LU1084165304.USD","IDNA","AGIO","VERX","XBI","NATO","BK4139","LU0058720904.USD","METV","LU0267386448.USD","SG9999001176.SGD","IE0002270589.USD","LU0157215616.USD","BK4588","ITA","LABU","LU0757428866.USD","GNMX","XAR","LU0417517546.SGD","EXI","LU1093756325.SGD","LU2089984988.USD","IE00B19Z9P08.USD","DFEN","IBBQ","IE0009355771.USD","PBE","PPA","GEHC","GE","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658918451","title":"Vertex Pharmaceuticals Incorporated : Bofa Global Research Adds Stock to Its US 1 List","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918451?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:47","pubTimestamp":1786452456,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN448154:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4533","LU0109394709.USD","SG9999001176.USD","LU2237438978.USD","BIB","LU1585245621.USD","LU0256863811.USD","LU1035775433.USD","LU0289739699.SGD","IBBQ","VRTX","LU0079474960.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU2417539215.USD","TBXU","BBH","LU0234570918.USD","IE00BJT1NW94.SGD","IE00B19Z9Z06.USD","LU2089984988.USD","LU1430594728.SGD","BK4567","LU0823416689.USD","IE0009355771.USD","IDNA","IE00BZ9MQY76.HKD","SG9999013999.USD","IE00BFTCPJ56.SGD","IE0002270589.USD","LU0058720904.USD","BK4588","LU0061475181.USD","LU0889565916.HKD","LU2324357040.USD","GNMX","LU2362541513.USD","LU1674673428.USD","LU2462157665.USD","SGXZ57979304.SGD","PBE","BK4139","LU1093756168.USD","LU1093756325.SGD","IE00B19Z9P08.USD","LU0417517546.SGD","SG9999001176.SGD","LU2468319806.SGD","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658918360","title":"Infinimmune Raises $75 Million Series a Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918360","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918360?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:32","pubTimestamp":1786451529,"startTime":"0","endTime":"0","summary":"BRIEF-Infinimmune Raises $75 Million Series A Financing To Advance Pipeline Of Human-Derived Antibodies For Atopic Dermatitis And Inflammatory DiseaseAug 11 (Reuters)-Regeneron Pharmaceuticals, Inc.RE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN4480DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0823434740.USD","LU0109394709.USD","IBB","LU0882574055.USD","LU0114720955.EUR","LU2362541273.HKD","LU0289739699.SGD","LU1974910355.USD","LU0320765992.SGD","LU2362541513.USD","IBBQ","BBH","LU2362540622.SGD","TBXU","BK4139","BK4585","LU2468319806.SGD","LU2106854487.HKD","LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","BK4588","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823434583.USD","LU1917777945.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658918187","title":"BIO-key International Enters into $2.5 Million Warrant Inducement Transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918187","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918187?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:30","pubTimestamp":1786451400,"startTime":"0","endTime":"0","summary":"HOLMDEL, N.J., Aug.  11, 2026  (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global innovator in Identity and Access Management (IAM) and biometric authentication solutions, today ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3342704/0/en/bio-key-international-enters-into-2-5-million-warrant-inducement-transaction.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1169589451.USD","BK4121","BK4585","LU1169590202.USD","BKYI","BIO","BK4097","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174341976","title":"Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1174341976","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174341976?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:08","pubTimestamp":1786450094,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) has issued a stock trading risk warning announcement, stating that it is a CRO enterprise primarily focused on the research and development of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WRND","GSKH","BK4588","BK4585","LFSC","SBIO","GDOC","APXH","IBB","PBE","BBP","BK0216","BK0102","BIOY","600721","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658499086","title":"Infinimmune: $75 Mln Series a Financing Co-Led by Regeneron Ventures and Playground Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2658499086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658499086?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449611,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN4480DE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU0114720955.EUR","LU2237438978.USD","TBXU","LU0053666078.USD","LU2023250504.SGD","BBH","LU0823434583.USD","LU0823416689.USD","IBB","LU2362541513.USD","LU2468319806.SGD","LU0882574055.USD","LU0058720904.USD","IBBQ","LU0289739699.SGD","LU2362541273.HKD","BK4139","LU2089984988.USD","REGN","LU1974910355.USD","LU1917777945.USD","LU2106854487.HKD","LU0109394709.USD","LU2362540622.SGD","LU0320765992.SGD","LU0889565916.HKD","LU0823434740.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658999232","title":"Vertex Pharmaceuticals added to ‘US 1 List’ at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2658999232","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658999232?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:50","pubTimestamp":1786441855,"startTime":"0","endTime":"0","summary":"BofA analysts added Vertex Pharmaceuticals (VRTX) to the firm’s “US 1 List.” The list represents BofA’s best investment ideas. Published first on T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-1-list-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-1-list-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1559883803.SGD","LU1069344957.HKD","LU2236285917.USD","BK4588","IE0009355771.USD","LU2324357040.USD","PBE","BK4533","BK4567","IBBQ","BBH","IE0002270589.USD","LU0566484027.USD","IE00BJT1NW94.SGD","LU0234570918.USD","VERX","LU0823416689.USD","LU0757428866.USD","LU2417539215.USD","LU0079474960.USD","LU1815336091.USD","SG9999001176.SGD","SG9999013999.USD","LU1035775433.USD","VRTX","IE00B894F039.SGD","LU0289739699.SGD","SG9999001176.USD","LU1093756168.USD","LU0417517546.SGD","LU1585245621.USD","LU2089984988.USD","TBXU","IDNA","LU1093756325.SGD","LU0109394709.USD","IE00BZ9MQY76.HKD","IBB","LU2468319806.SGD","GNMX","BIB","IE00B2B36J28.USD","IE0002141913.USD","BK4585","IE00BFTCPJ56.SGD","LU1674673428.USD","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118729610","title":"AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1118729610","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118729610?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:12","pubTimestamp":1786428745,"startTime":"0","endTime":"0","summary":"A research report from Orient Securities Company Limited highlights that as global regulatory shifts accelerate, the large-scale application of AI in pharmaceuticals is rapidly advancing. It has...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","BK4585","WRND","BK0276","BK0183","BIOY","BK1147","XLVI","APXH","GSKH","VTHR","BBP","BK0188","LFSC","CHAT","BK1564","PBE","03958","QTOC","BK0028","GDOC","IBB","600958","BK0012","AIPO","SBIO","AGIX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658961201","title":"Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $633 from $610","url":"https://stock-news.laohu8.com/highlight/detail?id=2658961201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658961201?lang=en_us&edition=fundamental","pubTime":"2026-08-11 13:08","pubTimestamp":1786424933,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN44809A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU0432979614.USD","BIB","GNMX","LU0079474960.USD","LU1778281490.HKD","IDNA","LU2089984988.USD","LU0109394709.USD","IBB","SG9999013999.USD","LU0417517546.SGD","LU0823416689.USD","IE00B19Z3581.USD","LU1430594728.SGD","SGXZ57979304.SGD","LU0061475181.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","LU2362541273.HKD","IE00BJJMRZ35.SGD","IE00B894F039.SGD","LU1093756168.USD","LU1585245621.USD","LU2417539215.USD","IE00B19Z3B42.SGD","LU0234570918.USD","BBH","LU1035775433.USD","SG9999001176.USD","VRTX","LU2362541513.USD","LU1069344957.HKD","BK4585","IE00BJT1NW94.SGD","BK4588","LU1093756325.SGD","LU2456880835.USD","LU2237438978.USD","IE0002270589.USD","TBXU","LU2362540622.SGD","PBE","LU2462157665.USD","LU0256863811.USD","BK4567","IE00B19Z9P08.USD","IBBQ","IE00B2B36J28.USD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129703553","title":"Breaking News","url":"https://stock-news.laohu8.com/highlight/detail?id=1129703553","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129703553?lang=en_us&edition=fundamental","pubTime":"2026-08-11 09:16","pubTimestamp":1786410994,"startTime":"0","endTime":"0","summary":"According to the Wall Street Journal, Anthropic told some investors it plans to further expand into healthcare and biotech.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658277957","title":"Lakefront Biotherapeutics Boosts Immunology Push With Ouro Deal and Strong Cash Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658277957","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658277957?lang=en_us&edition=fundamental","pubTime":"2026-08-11 06:37","pubTimestamp":1786401430,"startTime":"0","endTime":"0","summary":"Galapagos ( ($NL:LKFT) ) has shared an update. Lakefront Biotherapeutics and Gilead Sciences have completed the acquisition of Ouro Medicines, cons...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-boosts-immunology-push-with-ouro-deal-and-strong-cash-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-boosts-immunology-push-with-ouro-deal-and-strong-cash-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU2324357040.USD","SG9999015952.SGD","LU1674673428.USD","LU1023059063.AUD","LU0058720904.USD","SG9999015945.SGD","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU0122379950.USD","IBBQ","LU0861579265.USD","LU0882574055.USD","LU1778281490.HKD","LU2468319806.SGD","MEDI","IE00BSNM7G36.USD","BK4585","BK4588","LU1934455863.HKD","LU1066051498.USD","LU0889565916.HKD","BK4578","LU0823416689.USD","BMED","IE00B7SZLL34.SGD","BK4568","LU2089984988.USD","BK4532","TBXU","LU1061106388.HKD","BBH","LU0965508806.USD","LU1934455277.USD","BK4139","LU1066053197.SGD","IBB","LU0965509010.AUD","GILD","IE00B19Z3B42.SGD","LU0965509101.SGD","TMED","LU0234570918.USD","LU1037948541.HKD","BIB","LU0109394709.USD","IE00B3T34201.USD","LU1571399168.USD","IE0002270589.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658695197","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2658695197","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658695197?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:35","pubTimestamp":1786394100,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rose 1.52% to $417.20 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.06% to 7,753.11 and Dow Jones Industrial Average  falling 0.11% to 53,975.98.This was the stock's second consecutive day of gains.Amgen Inc. closed 0.29% below its 52-week high of $418.40, which the company reached on August 6th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.99% to $261.81, Pfizer Inc.  rose 1.08% to $27.05, and AbbVie Inc.  rose 0.78% to $247.97.Trading volume  remained 881,945 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU0109394709.USD","TBXU","IE0009355771.USD","BK4139","LU2089984988.USD","IE00BJT1NW94.SGD","PBE","LU2242646821.SGD","IBBQ","LU0868494617.USD","LU1057294990.SGD","LU0289739699.SGD","LU0889565916.HKD","BIB","BK4599","IE0002141913.USD","BK4566","IE00B4R5TH58.HKD","BK4581","LU2242652126.USD","LU2112291526.USD","IE00B2B36J28.USD","LU1061106388.HKD","04332","LU0122379950.USD","BK4534","PJP","IE00BFTCPJ56.SGD","BK4533","BBH","AMGN","IE00BJJMRZ35.SGD","IBB","LU1571399168.USD","LU0058720904.USD","SG9999001440.SGD","LU0320765992.SGD","LU1983299246.USD","BK4585","LU2468319806.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658562519","title":"Lakefront Biotherapeutics H1 FY26 Net Sales Drop 87% to EUR 18.6 Million; Operating Loss Narrows 54% to EUR 107.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658562519","media":"Reuters","labels":["shareholding","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658562519?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:04","pubTimestamp":1786392271,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics H1 FY26 net sales drop 87% to EUR 18.6 million; operating loss narrows 54% to EUR 107.2 millionLakefront Biotherapeutics posted a net profit of 16.6 million, swinging from a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL8C1FtB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","IE00BN0W2V16.EUR","SG9999015952.SGD","LU2095319765.USD","BK4585","NDAQ","SG9999014013.SGD","LU1934455277.USD","IE00BKVL7J92.USD","BMED","SG9999014005.SGD","BK4112","LU2087621335.USD","LU0234570918.USD","IBB","LU1037948897.HKD","TMED","BIB","GILD","LU2089984988.USD","BCDF","MEDI","BBH","IBBQ","BK4566","LU0289739699.SGD","LU1066051498.USD","SG9999015986.USD","LU1061106388.HKD","IE00BN0W2T93.GBP","TBXU","IE00B3T34201.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","LU1778281490.HKD","LU1839511570.USD","LU0114720955.EUR","LU0823416689.USD","LU1057294990.SGD","LU1585245621.USD","LU2210150020.SGD","BK4139","IE00BSNM7G36.USD","LU0314104364.USD","LU1430594728.SGD","SG9999014039.USD","LU0965509010.AUD","IE00BN0W2W23.USD","LU0058720904.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658958987","title":"Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658958987","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658958987?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:44","pubTimestamp":1786380254,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics'  STAT6 degrader NX-3911 is likely to receive increased recognition after advancing into clinical development under its collaboration with Sanofi , RBC Capital Markets said in a Monday research note.The investment firm said limited preclinical data suggest NX-3911 could be on relatively equal footing with Kymera Therapeutics'  KT-621, supporting higher value for Nurix when factoring in immunology and inflammation optionality across NX-3911, bex-deg and the rest of its pipeline.RBC expects NX-3911 to receive increased attention ahead of Kymera's STAT6 atopic dermatitis data expected by year-end, which could provide positive readthrough for Nurix's program. It noted that Sanofi is leading early clinical development of NX-3911, with a proof-of-concept dataset potentially available in the first half of 2027.The brokerage said bex-deg's chronic lymphocytic leukemia opportunity remains the core of its bullish thesis on Nurix, while the company also has optionality from its","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B3T34201.USD","LU0965509101.SGD","LU1585245621.USD","BK4532","TBXU","MEDI","LU0882574055.USD","IBBQ","LU0058720904.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","BK4566","LU1934455863.HKD","LU2112291526.USD","LU1057294990.SGD","SG9999015986.USD","IE0002270589.USD","LU1839511570.USD","LU1037948897.HKD","IE00BZ1G4Q59.USD","TMED","KYMR","SG9999015945.SGD","IE00BSNM7G36.USD","BBH","BK4007","LU1934455194.USD","BK4550","LU1674673428.USD","IBB","LU1066053197.SGD","BMED","LU0109394709.USD","IE00B7SZLL34.SGD","BK4585","GILD","LU0320765992.SGD","BK4139","LU2089984988.USD","LU2324357040.USD","LU1023059063.AUD","SNY","LU1934455277.USD","LU1571399168.USD","LU1430594728.SGD","NRIX","LU0965508806.USD","LU0823416689.USD","BK4588","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658663958","title":"Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658663958","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658663958?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:30","pubTimestamp":1786379412,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Jade Biosciences (JBIO), Silence Therapeutics (SLN) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-jade-biosciences-jbio-silence-therapeutics-sln-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-jade-biosciences-jbio-silence-therapeutics-sln-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU2237438978.USD","TBXU","XBI","BBH","LU2324357040.USD","LU0823416689.USD","VERX","IBB","LU0128526141.USD","LU1674673691.USD","LU2462157665.USD","LU2362541513.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","GNMX","LU2417539215.USD","LABU","LU0058720904.USD","IBBQ","IE0002270589.USD","LU1430594728.SGD","LU1674673428.USD","LU0234570918.USD","LU1778281490.HKD","LU0289739699.SGD","LU1069344957.HKD","SLN","LU2362541273.HKD","IE00B19Z9P08.USD","LU2456880835.USD","XLV","PBE","IE00B19Z3581.USD","HCSG","IE0002141913.USD","IE0009355771.USD","LU0029874061.USD","LU1559883803.SGD","LU1585245621.USD","JBIO","SG9999013999.USD","VRTX","IDNA","IE00BJT1NW94.SGD","BIB","LU0320765992.SGD","LU0566484027.USD","SG9999001176.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658930455","title":"Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658930455","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658930455?lang=en_us&edition=fundamental","pubTime":"2026-08-10 23:55","pubTimestamp":1786377312,"startTime":"0","endTime":"0","summary":"Shares of American biotech company Vertex Pharmaceuticals ($VRTX) jumped about 7% on Monday after its top rival Sionna Therapeutics ($SION) reporte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/vertex-stock-vrtx-soars-7-as-rival-sionna-sion-crashes-92-on-failed-drug-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/vertex-stock-vrtx-soars-7-as-rival-sionna-sion-crashes-92-on-failed-drug-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","SGXZ57979304.SGD","IE0002141913.USD","BK4533","IE00BJT1NW94.SGD","SION","LU2456880835.USD","LU0757428866.USD","LU2362541513.USD","LU1035775433.USD","LU0432979614.USD","IE00B19Z9Z06.USD","IE00B19Z3B42.SGD","BK4532","IDNA","BK4588","LU1430594728.SGD","PBE","VERX","LU2237438978.USD","BBH","LU0823416689.USD","LU0566484027.USD","LU1093756325.SGD","LU2417539215.USD","LU2462157665.USD","LU0889565916.HKD","LU1815336091.USD","LU2468319806.SGD","VRTX","LU2324357040.USD","IE00BFTCPJ56.SGD","GNMX","IE00B19Z9P08.USD","IE00B4R5TH58.HKD","XBIX","LU1674673428.USD","BK4139","BIB","TBXU","LU0061475181.USD","LU2362541273.HKD","NVIB","IBB","BK4585","LU2362540622.SGD","LU0417517546.SGD","LU0079474960.USD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130529376","title":"Vertex Pharmaceuticals jumps 7% after rival's drug trial fails to meet key goals","url":"https://stock-news.laohu8.com/highlight/detail?id=1130529376","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130529376?lang=en_us&edition=fundamental","pubTime":"2026-08-10 23:48","pubTimestamp":1786376892,"startTime":"0","endTime":"0","summary":"U.S. stock markets saw notable moves on Monday, with Vertex Pharmaceuticals (VRTX.US) surging nearly 7% in early trading to hit an all-time high. In contrast, competitor Sionna Therapeutics (SION.US)...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069344957.HKD","SG9999001176.USD","LU1585245621.USD","BK4532","LU2237438978.USD","SG9999013999.USD","TBXU","IBBQ","LU0058720904.USD","LU1093756168.USD","LU2462157665.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","LU2417539215.USD","LU0256863811.USD","SG9999001176.SGD","LU0289739699.SGD","PBE","IE0002141913.USD","IE0002270589.USD","IE00B4R5TH58.HKD","LU0061475181.USD","BBH","IE00BZ9MQY76.HKD","LU1674673428.USD","LU2236285917.USD","LU2362540622.SGD","LU2362541273.HKD","IBB","LU1674673691.USD","LU0109394709.USD","BK4585","VRTX","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","BIB","IBBJ","LU0432979614.USD","LU1035775433.USD","LU2089984988.USD","IE00B19Z9Z06.USD","LU0234570918.USD","LU2324357040.USD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","IE00B894F039.SGD","LU1093756325.SGD","LU2362541513.USD","LU0079474960.USD","LU1778281490.HKD","LU2456880835.USD","LU1430594728.SGD","GNMX","IDNA","LU0417517546.SGD","BK4533","BK4567","LU2468319806.SGD","LU0823416689.USD","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}